NeuroMod+: Co-creation for next-generation neuromodulation therapeutics

NeuroMod：共同创造下一代神经调节疗法

• 批准号: EP/W035057/1
• 负责人: Simon Schultz
• 金额: $ 161.29万
• 依托单位: Imperial College London
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FW035057%2F1
• 关键词: NeuroMod+; Co; creation; next; generation

The Neuromod+ network will represent UK research, industry, clinical and patient communities, working together to address the challenge of minimally invasive treatments for brain disorders. Increasingly, people suffer from debilitating and intractable neurological conditions, including neurodegenerative diseases and mental health disorders. Neurotechnology is playing an increasingly important part in solving these problems, leading to recent bioelectronic treatments for depression and dementia. However, the invasiveness of existing approaches limits their overall impact. Neuromod+ will bring together neurotechnology stakeholders to focus on the co-creation of next generation, minimally invasive brain stimulation technologies. The network will focus on transformative research, new collaborations, and facilitating responsible innovation, partnering with bioethicists and policy makers. As broadening the accessibility of brain modification technology my lead to unintended consequences, considering the ethical and societal implications of these technological development is of the utmost importance, and thus we will build in bioethics research as a core network activity. The activities of NEUROMOD+ will have global impact, consolidating the growing role of UK neurotechnology sector.

Neuromod+网络将代表英国研究，工业，临床和患者社区，共同努力应对脑部疾病微创治疗的挑战。越来越多的人患有衰弱和顽固的神经系统疾病，包括神经退行性疾病和精神健康障碍。神经技术在解决这些问题方面发挥着越来越重要的作用，导致最近的抑郁症和痴呆症的生物电子治疗。然而，现有方法的侵入性限制了它们的整体影响。Neuromod+将汇集神经技术利益相关者，专注于共同创造下一代微创脑刺激技术。该网络将重点关注变革性研究、新合作以及与生物伦理学家和政策制定者合作促进负责任的创新。随着大脑改造技术的普及可能导致意想不到的后果，考虑这些技术发展的伦理和社会影响至关重要，因此我们将把生物伦理学研究作为核心网络活动。NEUROMOD+的活动将产生全球影响，巩固英国神经技术部门日益增长的作用。